Uma Kavita

Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults

Christine B. Turley, Richard Rupp, Casey Johnson et al. · Vaccine · 2011 · 288 citations

Vaccinology, Vaccine Safety, Vaccination +8

CD1.1 Expression by Mouse Antigen-Presenting Cells and Marginal Zone B Cells

Jessica H. Roark, Se‐Ho Park, Jayanthi Jayawardena et al. · The Journal of Immunology · 1998 · 229 citations · Full text

Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)

David N. Taylor, John J. Treanor, Cynthia Strout et al. · Vaccine · 2011 · 160 citations

Vaccination, Vaccine Development, Allergy +10

Safety and immunogenicity of a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125) in healthy young adults

John J. Treanor, David N. Taylor, Lynda Tussey et al. · Vaccine · 2010 · 143 citations

Vaccinology, Vaccine Safety, Cross-protection +12

Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response

David N. Taylor, John J. Treanor, Eric Sheldon et al. · Vaccine · 2012 · 130 citations

Vaccination, Cross-protection, Vaccine Development +10